Latest news
Creating a winning team
The September issue of Pharmaceutical Marketing Europe features an article by Harten Group consultant Dr Malcolm Barratt-Johnson, exploring how competing challenges affecting the crucial relationship betweeen medics and marketers can often be overcome using simple techniques. Read the full article >>
Summer 2011 consultants' newsletter
Our latest newsletter is available here.
See our latest ad. in Pipeline!
Harten Group has been highlighting its significant expertise in the area of pharmacovigilance with advertisements in Pipeline magazine, the official publication for the Pharmaceutical Information & Pharmacovigilance Association. PIPA is the professional organisation for individuals who are involved in the provision and management of information and those involved in the fulfilment of regulatory requirements relating to drug safety. Advertisements have appeared in December and March, with a further insertion in the June issue.
The ad. highlights Harten Group's capability in terms of providing interim QPPVs, pharmaceutical physicians and senior drug safety managers to the industry. With over 350 specialist pharmacovigilance consultants registered, Harten Group has 16 years' experience of supporting 100 companies' drug safety operations on a wide range of PV projects - from individual interim management projects through to wider ranging strategic reviews. Further information >>
How to turn your inspection into a positive experience
In the March issue of Pipeline, the official publication for the Pharmaceutical & Pharmacovigilance Association (PIPA) is an article on the subject of inspections authored by Iain Cockburn, one of our consultants. PIPA is the professional organisation for individuals who are involved in the provision and management of information and those responsible for the fulfilment of regulatory requirements relating to drug safety. Entitled 'Inspections: How To Turn Yours Into A Positive Experience', the article covers the legal framework, inspection procedures, what happens during an inspection, typical non-compliance findings and how to interpret the results. Read the full article >>
New marketing campaign launched
This Autumn has seen the start of an exciting new six-month marketing campaign by Harten Group to remind the marketplace what we can offer - and, very importantly, to sell your services as consultants.
The initial campaign is focusing on pharmacovigilance services. We currently have over 350 specialist pharmacovigilance consultants registered with us and 16 years' experience of supporting 100 companies' drug safety operations, on a wide range of PV projects, from providing interims for a specific task through to a strategic look at drug safety procedures within a business.
Our campaign is including a number of co-ordinated elements: targeted mailings, press articles, advertisements, events, new pages on our website and the creation of a new set of marketing materials including brochures and postcards.
Dr Vernon Harten-Ash CEO said: "We feel the time is right to get out there and reinforce our core messages to one of our key target audiences. Pharmacovigilance services are becoming increasingly important as regulations get more complicated and inspections ever more rigorous.
"We will keep you updated on our progress in the next Consultants' newsletter but in the meantime if you see any opportunities that you think would be of interest to us, please don’t hesitate to get in touch. You might also earn some Reward Points! "